MedPath

Bariederm Cream in Chronic Contact Dermatitis

Not Applicable
Conditions
Contact Dermatitis
Interventions
Device: bariederm cream
Registration Number
NCT02026700
Lead Sponsor
Hadassah Medical Organization
Brief Summary

We intend to evaluate the efficiency and tolerability of a barrier cream (bariederm) in protecting hands of individuals with hand dermatitis, either due to allergy or irritation. We believe that the use of the cream would benefit with the skin.

Detailed Description

The aim of the study is the evaluation of the effectiveness, tolerance and cosmetic acceptability of Bariéderm cream among patients presenting with chronic allergic or irritant contact dermatitis of the hands. We shall enrol adults presenting with CONTACT DERMATITIS EXCLUDING FLARE-UPS of the hands: whether allergic or irritant, able to understand the protocol and agrees to sign the information and informed consent form. Bariéderm cream will be applied minimum twice daily over 21 days. Response will be evaluated by self and physician filled questionnaires. effectiveness, tolerance and cosmetic acceptability will be evaluated by a scale of 1-10, 1 meaning "not at all" and 10 meaning "very much". Statistics will be performed by SPSS software with suitable statistical tests. In case of an adverse event caused by the product, patch-test with ingredients of Bariéderm cream will be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • patients with dermatitis of the hands
Exclusion Criteria
  • pregnant ladies,
  • known allergy to ingredients -

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
bariederm, barrier creambariederm creamone arm study: use of bariederm cream on hands twice daily for 21 days
Primary Outcome Measures
NameTimeMethod
self evaluation of effectiveness and tolerance in a 1-10 scale21 days

effectiveness tolerance and acceptability in adults with hand dermatitis, evaluated by a self reported and a physician reported questionaires, using a 1-10 scale for evaluation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

: Hadassah Medical Organization, Jerusalem, Israel

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath